INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK — Neutral
GSK GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

LEU vs. NXE: Which Uranium Stock is the Better Pick Now? — Positive
LEU NXE Zacks Investment Research — July 28, 2025Centrus Energy boasts HALEU leadership and soaring sales; NexGen Energy holds a high-grade asset poised to reshape uranium production.

Should You Buy, Sell or Hold CCJ Stock Before Q2 Earnings Release? — Neutral
CCJ Zacks Investment Research — July 28, 2025Cameco is set to post sharply higher Q2 revenues and EPS, but an earnings beat may remain out of reach.

Large-Cap Growth ETF (SPYG) Touches New 52-Week High — Positive
SPYG Zacks Investment Research — July 28, 2025SPYG hits a 52-week high as growth stocks surge on strong earnings, easing inflation and rate cut hopes.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN — Neutral
DYN GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Global DC savings still decades from resolving retirement cash crunch fears — Neutral
WTW GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Many defined contribution (DC) plans remain unconvinced that members are on track for sufficient income in retirement and expect the time frame to reverse this to take decades, according to new research by leading global advisory, broking and solutions company WTW's (NASDAQ: WTW) Thinking Ahead Institute.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL — Neutral
REPL GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the “Company”)(NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Superior HealthPlan and Centene Foundation Announce Grand Opening of CHDI Multi-Purpose Community Health Center in Uvalde — Neutral
CNC PRNewsWire — July 28, 2025The $16 million center is managed by Community Health Development, Inc., and offers healthcare services, community support, and other resources UVALDE, Texas , July 28, 2025 /PRNewswire/ -- Superior HealthPlan and the Centene Foundation, the philanthropic arm of Centene (NYSE: CNC), today joined Community Health Development, Inc. (CHDI) to open a new $16 million multi-purpose community health center in Uvalde. The 16,000-square-foot space provides healthcare services, community support and outreach, education and workforce development, and a meeting space for the Uvalde community and the surrounding region.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MarineMax, Inc. – HZO — Neutral
HZO GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. (“MarineMax” or the “Company”) (NYSE: HZO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fiserv, Inc. of Class Action Lawsuit and Upcoming Deadlines - FI — Neutral
FI GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or the “Company”)(NYSE: FI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

UWM Holdings: A Bet Against The Interest Rate Consensus — Positive
UWMC Seeking Alpha — July 28, 2025UWM Holdings Corporation is a top mortgage lender with scale advantages, high insider ownership, and a consistent, attractive 9%+ dividend yield. The company is highly leveraged to interest rates; a rate-cutting cycle would significantly boost earnings and share price. Current market pessimism is already priced in, making UWMC undervalued versus peers like Rocket, with downside risk limited by the dividend.

Gold sells off as greenback sees sharp gains — Negative
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — July 28, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Barnes & Noble Education, Inc. - BNED — Neutral
BNED GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. (“Barnes & Noble” or the “Company”) (NYSE: BNED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dow Inc. – DOW — Neutral
DOW GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. (“Dow” or the “Company”) (NYSE: DOW). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST — Neutral
RXST GlobeNewsWire — July 28, 2025NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Cutting Costs Key for UPS Turnaround, Dividend in Crosshairs — Negative
UPS Schwab Network — July 28, 2025Marley Kayden says "to say expectations are low is fair" for UPS Inc. (UPS), however, you may not want to count the stock out. While UPS faces tariff pricing pressures and a cut to its dividend, Marley points the company's aggressive cost cutting measures as a way to balance losses.

Bitcoin Depot Rides on Kiosk Expansion: Bullish on Bitcoin Potential? — Positive
BTM Zacks Investment Research — July 28, 2025BTM rides a 228% share surge as it scales kiosk expansion, crypto deals and Bitcoin holdings to fuel growth.

CCL vs. NCLH: Which Cruise Stock is the Better Buy Now? — Positive
CCL NCLH Zacks Investment Research — July 28, 2025Carnival rides on strong bookings, margin gains and earnings momentum, while Norwegian Cruise trails with softer growth and cost pressures.

Carter's Q2 Results Were Not Good, And Tariffs' Impact Is Still Incoming — Neutral
CRI Seeking Alpha — July 28, 2025Carter's posted positive comp sales and unit growth, signaling market share gains despite a declining US baby population. Profitability sharply deteriorated, with adjusted operating income down 75% and GAAP profits nearly breakeven due to price cuts, off-price sales, and rising SG&A. Upcoming tariffs pose major cost headwinds, and planned price increases may not be fully absorbed by consumers, risking further volume and profit declines.

SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT — Neutral
SRPT PRNewsWire — July 28, 2025LOS ANGELES , July 28, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws. Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.
